Frontlight ResearchEarly access
Trial site
Ordensklinikum Linz GmbH - Barmherzige Schwestern
- 7running trials
- 5closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Gastric and oesophageal cancer2 trials
- Metastatic breast cancer2 trials
- Primary biliary cholangitis2 trials
- Fatty liver disease (MASLD/MASH)1 trial
- Head and neck cancer1 trial
- Liver cirrhosis1 trial
- Lung cancer1 trial
- Pancreatic cancer1 trial
- Sarcoma1 trial
- Phase
- Phase 35 trials
- Phase 22 trials
- Phase 11 trial
- Phase 2/31 trial
- Status
- Active, not recruiting5 trials
- Completed5 trials
- Recruiting2 trials
- Lead sponsor
- Boehringer Ingelheim2 trials
- Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company2 trials
- Ipsen2 trials
- Calliditas Therapeutics Suisse SA1 trial
- ExpreS2ion Biotechnologies1 trial
- and 4 more
Running trials
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Head and neck cancer1 recruiting
- Metastatic breast cancer1 recruiting
Closed trials
Completed
A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026